Johansson L, Björnsson E, Nielsen H. "Method for the Synthesis of 101038-93-1
3-Glutathionyl-S-methylindole
L-|A-Glutamyl-S-(1H-indol-3-ylmethyl)-L-cysteinylglycine
N-[N-L-|A-Glutamyl-S-(1H-indol-3-ylmethyl)-L-cysteinyl]glycine" [P]. European Patent, EP 3704938 A1, 2020-04-05.
Rossi M, Björnsson E, Lefèvre J P. "A Process for Preparing High-Purity 101038-93-1
3-Glutathionyl-S-methylindole
L-|A-Glutamyl-S-(1H-indol-3-ylmethyl)-L-cysteinylglycine
N-[N-L-|A-Glutamyl-S-(1H-indol-3-ylmethyl)-L-cysteinyl]glycine" [P]. European Patent, EP 3597540 A1, 2018-09-11.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2010, 1347, (10), 5317-5336.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2010, 1633, 1595-1602.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 101038-93-1
3-Glutathionyl-S-methylindole
L-|A-Glutamyl-S-(1H-indol-3-ylmethyl)-L-cysteinylglycine
N-[N-L-|A-Glutamyl-S-(1H-indol-3-ylmethyl)-L-cysteinyl]glycine Using HRMS and NMR". Anal. Methods, 2014, 2345, (7), 316-329.